Early Data Show Moderna’s Coronavirus Vaccine Is 94.5% Effective
11/18/20
< < Go Back
from The New York Times,
11/18/20:
Moderna is the second company to report preliminary results from a large trial testing a vaccine. But there are still months to go before it will be widely available to the public.
More From The New York Times (subscription required):
Rss Feed